Siyu Fu[Author] - Search Results

Year	Number of Results
2002	1
2005	1
2009	1
2010	1
2018	1
2019	4
2020	4
2021	1
2022	5
2023	11
2024	3

1

DNA methylation markers in the detection of hepatocellular carcinoma.

Fu S, Debes JD, Boonstra A. Fu S, et al. Eur J Cancer. 2023 Sep;191:112960. doi: 10.1016/j.ejca.2023.112960. Epub 2023 Jun 28. Eur J Cancer. 2023. PMID: 37473464 Free article. Review.

2

Advances in Drug Therapy for Alzheimer's Disease.

Zhu CC, Fu SY, Chen YX, Li L, Mao RL, Wang JZ, Liu R, Liu Y, Wang XC. Zhu CC, et al. Curr Med Sci. 2020 Dec;40(6):999-1008. doi: 10.1007/s11596-020-2281-2. Epub 2021 Jan 11. Curr Med Sci. 2020. PMID: 33428127 Review.

3

Medicinal chemistry strategies targeting PRMT5 for cancer therapy.

Fu S, Zheng Q, Zhang D, Lin C, Ouyang L, Zhang J, Chen L. Fu S, et al. Eur J Med Chem. 2022 Dec 15;244:114842. doi: 10.1016/j.ejmech.2022.114842. Epub 2022 Oct 14. Eur J Med Chem. 2022. PMID: 36274274 Review.

4

Emerging opportunities to treat idiopathic pulmonary fibrosis: Design, discovery, and optimizations of small-molecule drugs targeting fibrogenic pathways.

Luo W, Gu Y, Fu S, Wang J, Zhang J, Wang Y. Luo W, et al. Among authors: fu s. Eur J Med Chem. 2023 Nov 15;260:115762. doi: 10.1016/j.ejmech.2023.115762. Epub 2023 Aug 25. Eur J Med Chem. 2023. PMID: 37683364 Review.

5

Insight into the role of TRAIL in liver diseases.

Jiang W, Wu DB, Fu SY, Chen EQ, Tang H, Zhou TY. Jiang W, et al. Biomed Pharmacother. 2019 Feb;110:641-645. doi: 10.1016/j.biopha.2018.12.004. Epub 2018 Dec 10. Biomed Pharmacother. 2019. PMID: 30544063 Free article. Review.

6

Molecular Biomarkers in Drug-Induced Liver Injury: Challenges and Future Perspectives.

Fu S, Wu D, Jiang W, Li J, Long J, Jia C, Zhou T. Fu S, et al. Front Pharmacol. 2020 Jan 30;10:1667. doi: 10.3389/fphar.2019.01667. eCollection 2019. Front Pharmacol. 2020. PMID: 32082163 Free PMC article. Review.

7

Validation and optimization of AFP-based biomarker panels for early HCC detection in Latin America and Europe.

Beudeker BJB, Fu S, Balderramo D, Mattos AZ, Carrera E, Diaz J, Prieto J, Banales J, Vogel A, Arrese M, Oliveira J, Groothuismink ZMA, van Oord G, Hansen BE, de Man RA, Debes JD, Boonstra A. Beudeker BJB, et al. Among authors: fu s. Hepatol Commun. 2023 Sep 15;7(10):e0264. doi: 10.1097/HC9.0000000000000264. eCollection 2023 Oct 1. Hepatol Commun. 2023. PMID: 37708457 Free PMC article.

8

Advancements in dual-target inhibitors of PI3K for tumor therapy: Clinical progress, development strategies, prospects.

Hu J, Fu S, Zhan Z, Zhang J. Hu J, et al. Among authors: fu s. Eur J Med Chem. 2024 Feb 5;265:116109. doi: 10.1016/j.ejmech.2023.116109. Epub 2023 Dec 31. Eur J Med Chem. 2024. PMID: 38183777 Review.

9

Discovery of benzamide derivatives containing urea moiety as soluble epoxide hydrolase inhibitors.

Tian Y, Li S, Dong K, Su X, Fu S, Lv X, Duan M, Yang T, Han Y, Hu G, Liu J, Sun Y, Yue H, Sun Y, Zhang H, Du Z, Miao Z, Tong M, Liu Y, Qin M, Gong P, Hou Y, Gao Z, Zhao Y. Tian Y, et al. Among authors: fu s. Bioorg Chem. 2022 Oct;127:105898. doi: 10.1016/j.bioorg.2022.105898. Epub 2022 May 24. Bioorg Chem. 2022. PMID: 35792317

10

Hypermethylation of DNA Methylation Markers in Non-Cirrhotic Hepatocellular Carcinoma.

Fu S, Deger T, Boers RG, Boers JB, Doukas M, Gribnau J, Wilting SM, Debes JD, Boonstra A. Fu S, et al. Cancers (Basel). 2023 Sep 28;15(19):4784. doi: 10.3390/cancers15194784. Cancers (Basel). 2023. PMID: 37835478 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

27 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Results by year